SEC Form 4 · accession 0000914190-15-000204
Cardiovascular Systems Inc · CSII
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brent G Blackey
Director
Period of report
May 1, 2015
Accepted (ET)
May 5, 2015 · 5:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001180145
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 1, 2015 | P | 2,500 | $29.38 | A | 57,145 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $7.90 | holding | — | — | — | — | Oct 8, 2017 | Common Stock | 38,820 | 38,820 | D |
| Stock Option (right to buy)F2 | $7.90 | holding | — | — | — | — | Oct 8, 2017 | Common Stock | 6,470 | 6,470 | D |
| Restricted Stock UnitsF3 | — | holding | — | — | — | — | — | Common Stock | 5,714 | 5,714 | D |
| Restricted Stock UnitsF3 | — | holding | — | — | — | — | — | Common Stock | 11,628 | 11,628 | D |
| Restricted Stock UnitsF3 | — | holding | — | — | — | — | — | Common Stock | 21,739 | 21,739 | D |
| Restricted Stock UnitsF3 | — | holding | — | — | — | — | — | Common Stock | 7,192 | 7,192 | D |
| Restricted Stock UnitsF3 | — | holding | — | — | — | — | — | Common Stock | 10,917 | 10,917 | D |
| Restricted Stock UnitsF4 | — | holding | — | — | — | Aug 13, 2015 | Aug 13, 2015 | Common Stock | 2,749 | 2,749 | D |
| Restricted Stock UnitsF3 | — | holding | — | — | — | — | — | Common Stock | 4,580 | 4,580 | D |
| Restricted Stock UnitsF4 | — | holding | — | — | — | Aug 31, 2016 | Aug 31, 2016 | Common Stock | 2,045 | 2,045 | D |
| Restricted Stock UnitsF5 | — | holding | — | — | — | — | — | Common Stock | 4,260 | 4,260 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $29.32 to $29.40 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- F2Fully exercisable.
- F3Each restricted stock unit represents the right to receive a payment from CSI equal in value to the market price per share of CSI common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning six months following the termination of each director's board membership.
- F4Each restricted stock unit represents the right to receive a payment from CSI equal in value to the market price per share of CSI common stock on the date of payment and shall be payable in cash or shares of Company common stock on the payment date.
- F5Each restricted stock unit represents the right to receive a payment from CSI equal in value to the market price per share of CSI common stock on the date of payment, and shall be payable in cash or shares of Company common stock beginning six months following the termination of each director's board membership; provided, however, that the restricted stock units vest in quarterly amounts of 1,065 on each of September 30, 2014, December 31, 2014, March 31, 2015 and June 30, 2015.